vs
Side-by-side financial comparison of FOX FACTORY HOLDING CORP (FOXF) and Bio-Techne (TECH). Click either name above to swap in a different company.
FOX FACTORY HOLDING CORP is the larger business by last-quarter revenue ($361.1M vs $311.4M, roughly 1.2× Bio-Techne). On growth, FOX FACTORY HOLDING CORP posted the faster year-over-year revenue change (2.3% vs -1.5%). Over the past eight quarters, FOX FACTORY HOLDING CORP's revenue compounded faster (1.8% CAGR vs 1.3%).
Fox Factory Holding Corp. is an American company best known for their Fox Racing Shox brand of off-road racing suspension components.
Bio-Techne Corporation is an American life sciences company that develops, manufactures and sells life science reagents, instruments and services for the research, diagnostic, and bioprocessing markets.
FOXF vs TECH — Head-to-Head
Income Statement — Q4 FY2027 vs Q3 FY2026
| Metric | | |
|---|---|---|
| Revenue | $361.1M | $311.4M |
| Net Profit | — | $51.0M |
| Gross Margin | 28.3% | 66.9% |
| Operating Margin | -13.0% | 24.2% |
| Net Margin | — | 16.4% |
| Revenue YoY | 2.3% | -1.5% |
| Net Profit YoY | — | 126.0% |
| EPS (diluted) | $-6.86 | $0.32 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q4 26 | $361.1M | — | ||
| Q1 26 | $368.7M | $311.4M | ||
| Q4 25 | $376.4M | $295.9M | ||
| Q3 25 | $374.9M | — | ||
| Q2 25 | $355.0M | $317.0M | ||
| Q1 25 | $352.8M | $316.2M | ||
| Q4 24 | — | $297.0M | ||
| Q3 24 | $359.1M | $289.5M |
| Q4 26 | — | — | ||
| Q1 26 | $-15.0M | $51.0M | ||
| Q4 25 | $-634.0K | $38.0M | ||
| Q3 25 | $2.7M | — | ||
| Q2 25 | $-259.7M | $-17.7M | ||
| Q1 25 | $-141.0K | $22.6M | ||
| Q4 24 | — | $34.9M | ||
| Q3 24 | $4.8M | $33.6M |
| Q4 26 | 28.3% | — | ||
| Q1 26 | 28.9% | 66.9% | ||
| Q4 25 | 30.4% | 64.6% | ||
| Q3 25 | 31.2% | — | ||
| Q2 25 | 30.9% | 62.7% | ||
| Q1 25 | 28.9% | 67.9% | ||
| Q4 24 | — | 65.3% | ||
| Q3 24 | 29.9% | 63.2% |
| Q4 26 | -13.0% | — | ||
| Q1 26 | 72.8% | 24.2% | ||
| Q4 25 | 4.0% | 18.4% | ||
| Q3 25 | 4.9% | — | ||
| Q2 25 | -70.6% | -7.5% | ||
| Q1 25 | 3.2% | 12.2% | ||
| Q4 24 | — | 16.0% | ||
| Q3 24 | 5.2% | 13.8% |
| Q4 26 | — | — | ||
| Q1 26 | -4.1% | 16.4% | ||
| Q4 25 | -0.2% | 12.8% | ||
| Q3 25 | 0.7% | — | ||
| Q2 25 | -73.1% | -5.6% | ||
| Q1 25 | -0.0% | 7.1% | ||
| Q4 24 | — | 11.7% | ||
| Q3 24 | 1.3% | 11.6% |
| Q4 26 | $-6.86 | — | ||
| Q1 26 | $-0.36 | $0.32 | ||
| Q4 25 | $-0.02 | $0.24 | ||
| Q3 25 | $0.07 | — | ||
| Q2 25 | $-6.23 | $-0.11 | ||
| Q1 25 | $0.00 | $0.14 | ||
| Q4 24 | — | $0.22 | ||
| Q3 24 | $0.11 | $0.21 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $58.0M | $209.8M |
| Total DebtLower is stronger | $26.9M | — |
| Stockholders' EquityBook value | $670.2M | $2.1B |
| Total Assets | $1.7B | $2.6B |
| Debt / EquityLower = less leverage | 0.04× | — |
8-quarter trend — quarters aligned by calendar period.
| Q4 26 | $58.0M | — | ||
| Q1 26 | $53.9M | $209.8M | ||
| Q4 25 | — | $172.9M | ||
| Q3 25 | — | — | ||
| Q2 25 | — | $162.2M | ||
| Q1 25 | $71.7M | $140.7M | ||
| Q4 24 | — | $177.5M | ||
| Q3 24 | — | $187.5M |
| Q4 26 | $26.9M | — | ||
| Q1 26 | $26.9M | — | ||
| Q4 25 | $536.7M | $260.0M | ||
| Q3 25 | $541.8M | — | ||
| Q2 25 | $546.9M | $346.0M | ||
| Q1 25 | $552.1M | $330.0M | ||
| Q4 24 | — | $300.0M | ||
| Q3 24 | $558.4M | $300.0M |
| Q4 26 | $670.2M | — | ||
| Q1 26 | $658.8M | $2.1B | ||
| Q4 25 | $956.0M | $2.0B | ||
| Q3 25 | $958.7M | — | ||
| Q2 25 | $939.9M | $1.9B | ||
| Q1 25 | $1.2B | $2.0B | ||
| Q4 24 | — | $2.1B | ||
| Q3 24 | $1.2B | $2.1B |
| Q4 26 | $1.7B | — | ||
| Q1 26 | $1.7B | $2.6B | ||
| Q4 25 | $2.0B | $2.5B | ||
| Q3 25 | $2.0B | — | ||
| Q2 25 | $1.9B | $2.6B | ||
| Q1 25 | $2.2B | $2.6B | ||
| Q4 24 | — | $2.7B | ||
| Q3 24 | $2.3B | $2.7B |
| Q4 26 | 0.04× | — | ||
| Q1 26 | 0.04× | — | ||
| Q4 25 | 0.56× | 0.13× | ||
| Q3 25 | 0.57× | — | ||
| Q2 25 | 0.58× | 0.18× | ||
| Q1 25 | 0.46× | 0.16× | ||
| Q4 24 | — | 0.14× | ||
| Q3 24 | 0.47× | 0.14× |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | $60.9M | — |
| Free Cash FlowOCF − Capex | — | — |
| FCF MarginFCF / Revenue | — | — |
| Capex IntensityCapex / Revenue | — | — |
| Cash ConversionOCF / Net Profit | — | — |
| TTM Free Cash FlowTrailing 4 quarters | — | — |
8-quarter trend — quarters aligned by calendar period.
| Q4 26 | $60.9M | — | ||
| Q1 26 | — | — | ||
| Q4 25 | $5.3M | — | ||
| Q3 25 | $36.8M | — | ||
| Q2 25 | $680.0K | $98.2M | ||
| Q1 25 | $81.7M | $41.1M | ||
| Q4 24 | — | $84.3M | ||
| Q3 24 | $14.1M | $63.9M |
| Q4 26 | — | — | ||
| Q1 26 | — | — | ||
| Q4 25 | $-2.5M | — | ||
| Q3 25 | $24.6M | — | ||
| Q2 25 | $-6.5M | $93.3M | ||
| Q1 25 | $69.8M | $31.0M | ||
| Q4 24 | — | $77.5M | ||
| Q3 24 | $3.2M | $54.7M |
| Q4 26 | — | — | ||
| Q1 26 | — | — | ||
| Q4 25 | -0.7% | — | ||
| Q3 25 | 6.6% | — | ||
| Q2 25 | -1.8% | 29.4% | ||
| Q1 25 | 19.8% | 9.8% | ||
| Q4 24 | — | 26.1% | ||
| Q3 24 | 0.9% | 18.9% |
| Q4 26 | — | — | ||
| Q1 26 | — | — | ||
| Q4 25 | 2.1% | — | ||
| Q3 25 | 3.3% | — | ||
| Q2 25 | 2.0% | 1.5% | ||
| Q1 25 | 3.4% | 3.2% | ||
| Q4 24 | — | 2.3% | ||
| Q3 24 | 3.0% | 3.2% |
| Q4 26 | — | — | ||
| Q1 26 | — | — | ||
| Q4 25 | — | — | ||
| Q3 25 | 13.41× | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | 1.82× | ||
| Q4 24 | — | 2.42× | ||
| Q3 24 | 2.94× | 1.90× |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
Revenue Breakdown by Segment
FOXF
| Aftermarket Applications Group | $126.2M | 35% |
| Specialty Sports Group | $118.2M | 33% |
| Powered Vehicles Group | $116.7M | 32% |
TECH
| Protein Sciences segment revenue | $226.2M | 73% |
| Diagnostics and Spatial Biology segment revenue | $85.6M | 27% |
| Other revenue (1) | $5.4M | 2% |
